Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Inventory (2021 - 2025)

Historic Inventory for Macrogenics (MGNX) over the last 5 years, with Q3 2025 value amounting to $8.8 million.

  • Macrogenics' Inventory rose 17127.0% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year increase of 17127.0%. This contributed to the annual value of $1.2 million for FY2023, which is 1585.11% down from last year.
  • Macrogenics' Inventory amounted to $8.8 million in Q3 2025, which was up 17127.0% from $9.3 million recorded in Q2 2025.
  • In the past 5 years, Macrogenics' Inventory registered a high of $9.4 million during Q1 2025, and its lowest value of $1.1 million during Q3 2023.
  • For the 5-year period, Macrogenics' Inventory averaged around $3.9 million, with its median value being $3.1 million (2022).
  • In the last 5 years, Macrogenics' Inventory crashed by 7270.67% in 2022 and then skyrocketed by 73408.07% in 2025.
  • Macrogenics' Inventory (Quarter) stood at $4.4 million in 2021, then crashed by 66.93% to $1.5 million in 2022, then fell by 15.85% to $1.2 million in 2023, then surged by 165.68% to $3.2 million in 2024, then skyrocketed by 171.27% to $8.8 million in 2025.
  • Its last three reported values are $8.8 million in Q3 2025, $9.3 million for Q2 2025, and $9.4 million during Q1 2025.